Trusted Resource for Clinical Trials, Protocols & Progress
The purpose of this SOP is to outline standardized procedures for the receipt and verification of investigational products (IP) at clinical trial sites. This ensures that the product is received in good condition, verified against shipping documents, and appropriately recorded for accountability and regulatory compliance.
Click to read the full article.
The purpose of this SOP is to establish standardized procedures for the storage, temperature monitoring, and excursion management of investigational products (IP) at clinical trial sites. Proper storage safeguards product integrity, ensures participant safety, and maintains compliance with regulatory requirements.
Click to read the full article.
The purpose of this SOP is to establish standardized procedures for dispensing and administering investigational products (IP) to trial participants. It ensures that IP is dispensed accurately, administered safely, and recorded appropriately in compliance with Good Clinical Practice (GCP) and regulatory standards.
Click to read the full article.
The purpose of this SOP is to establish procedures for the return and destruction of investigational products (IP) used in clinical trials. This ensures unused, expired, or damaged IP is managed responsibly, maintaining compliance with ethical, regulatory, and environmental standards.
Click to read the full article.
The purpose of this SOP is to define procedures for reconciliation and accountability of investigational products (IP) throughout the lifecycle of a clinical trial. Accurate reconciliation ensures that all IP is tracked from receipt to dispensing, return, or destruction, thus protecting participant safety and ensuring compliance with regulatory guidelines.
Click to read the full article.
The purpose of this SOP is to describe standardized procedures for randomization, blinding, and unblinding in clinical trials. These processes ensure unbiased allocation of investigational products, maintain trial integrity, and safeguard subject safety.
Click to read the full article.
The purpose of this SOP is to establish detailed procedures for handling controlled substances in clinical trials. Controlled drugs, including narcotics and psychotropic substances, require stringent oversight to ensure subject safety, prevent diversion, and maintain compliance with national and international regulations.
Click to read the full article.
The purpose of this SOP is to outline clear procedures for the safe handling and management of spillage or incidents involving investigational products (IP) and biological materials in clinical trials. It ensures protection of staff, subjects, and the environment while maintaining proper documentation and regulatory compliance.
Click to read the full article.
The purpose of this SOP is to outline the procedures for labeling investigational products (IP) intended for clinical trial use. Proper labeling ensures subject safety, product traceability, and compliance with international regulatory standards, while safeguarding blinding requirements where applicable.
Click to read the full article.
The purpose of this SOP is to define standardized procedures for the identification, classification, and documentation of serious adverse events (SAEs) during clinical trials. This ensures subject safety, accurate reporting, and compliance with applicable regulatory frameworks.
Click to read the full article.
